Shares of IBM (NYSE:IBM | IBM Price Prediction) are up 7% in early trading Monday to $320 and change, extending a historic May rally into June. Pure-play quantum names IonQ (NYSE:IONQ) and Rigetti Computing (NASDAQ:RGTI) are moving in the opposite direction, with IONQ stock down 4% to around $69 and RGTI stock down 4% to $24 and change.
The divergence reflects capital concentrating in the legacy quantum player rather than spreading across the speculative complex. IBM just delivered its best monthly performance in nearly 24 years, gaining 32% over the past month.
IonQ stock had climbed 71% over the past month before today’s pullback, while Rigetti stock had gained 59% in the same window. The quantum trade has been red-hot across the board, and today’s session shows the institutional bid funneling into IBM stock.
$10 Billion Quantum Commitment Anchors the Bid
IBM announced a $10 billion investment in quantum computing over the next five years, aiming for a commercial fault-tolerant quantum computer by 2029. The commitment is anchored by Anderon, a new IBM-backed quantum chip foundry in New York supported by a $1 billion CHIPS Act federal grant that IBM is matching dollar-for-dollar.
The broader $15 billion announcement also includes $5 billion for Project Lightwell, a Red Hat initiative focused on open-source software security using AI. IBM CEO Arvind Krishna recently stated that “AI continues to be a tailwind for our global business,” with IBM’s generative AI book of business surpassing $12.5 billion inception-to-date.
Wall Street has piled on the bull case. Wedbush’s Dan Ives called IBM the center of a “$1 trillion value creation engine,” while Barclays carries an Overweight rating with a $350 price target, Wedbush reaffirmed Outperform at $320, and RBC holds Outperform with a $300 target.
President Trump’s public praise of IBM and Krishna has also energized a “Trump play” narrative across Stocktwits and social media circles. Reddit sentiment scores ran bullish at 62 to 68 on r/stockmarket and r/WallStreetBets through Sunday, then moderated to neutral readings of 50 to 58 as discussion shifted to r/options for tactical positioning.
IonQ and Rigetti Give Back After Monstrous Runs
IonQ posted Q1 2026 revenue of $64.67 million, up 755% year over year and 30% above the midpoint of prior guidance. The company raised full-year revenue guidance to $260 million to $270 million and continues to advance its pending SkyWater Technology acquisition.
Rigetti reported Q1 revenue of $4.4 million, nearly tripling year over year, with a cash position of $569 million and no debt. The company’s 108-qubit Cepheus-1-108Q system is in general availability, and Rigetti has committed up to $100 million toward a UK expansion targeting a 1,000-plus qubit system over three to four years.
Today’s pullback in IonQ stock and Rigetti stock reads as classic profit-taking after powerful runs. The underlying fundamentals remain intact for both pure-plays. The market is simply rewarding IBM’s combination of scale, government partnership, and established enterprise relationships today.
Why the Concentration Trade Favors IBM
IBM stock now trades at a P/E ratio of 26x, with insider activity showing a net buying posture across 13 recent transactions. Analyst ratings tilt positive at 11 Buy, 9 Hold, and 1 Sell, with a consensus target around $277.68.
Prediction market data adds another layer. The Polymarket reading of the U.S. federal government stake market puts IonQ at 50/50 odds for federal equity participation by year-end, while semiconductor incumbents like GlobalFoundries sit near 70%. The U.S. has already taken minority equity stakes in nine quantum companies totaling about $2 billion via the CHIPS and Science Act.
IBM also offers a dividend, lower beta, and decades of enterprise customer relationships. That mix is exactly what an institutional rotation favors when the speculative end of the quantum trade gets crowded. IBM’s Q1 revenue grew over 2% above expectations to $15.9 billion, reinforcing the case that scale plus quantum optionality is the cleaner trade.
What to Watch
Investors can watch for follow-through on Anderon foundry construction, additional U.S. government equity announcements across the quantum complex, and whether IonQ stock and Rigetti stock find buyers after today’s pullback. The bull case for IBM rests on execution against the 2029 fault-tolerant target.
The level to watch is whether IBM stock holds above the $320 area into the close. A clean finish could pull more sector capital toward IBM, while a fade would suggest that today’s bid was more about positioning than conviction. Either way, the rotation within the quantum trade is the story to track this week.
Top Gaining Stocks
Top Losing Stocks